SOUTH SAN FRANCISCO, Calif. – October 29, 2015 – Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the third quarter ended September 30, 2015. Total revenue for the third quarter of 2015 was $28.6 million, a decrease of 3% from $29.6 million in the third quarter of
Through an innovative and entrepreneurial approach to genomics medicine, the Centre intends to accelerate scientific discoveries. MELBOURNE, Australia and SOUTH SAN FRANCISCO, California, Sept. 4, 2015 – A partnership among Monash University, the University of Melbourne, the University of
Now Every Laboratory can have Access to Large-Scale Surveys of Heterogeneity SOUTH SAN FRANCISCO, California, Aug. 25, 2015 – Fluidigm Corporation (NASDAQ: FLDM) today announced commercial availability of a new high throughput single-cell mRNA sequencing workflow for its C1™ system to enable
SOUTH SAN FRANCISCO, Calif. – August 6, 2015 – Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the second quarter ended June 30, 2015. Total revenue for the second quarter of 2015 was $28.6 million, an increase of 4% from $27.6 million in the second quarter of 2014.
Company’s New Branding and Logo Receives Honorable Mention SOUTH SAN FRANCISCO, Calif., June 3, 2015 – Fluidigm Corporation (NSADAQ:FLDM) announced that its Juno™ system, an advanced platform for genotyping and sample prep, was a Gold Award winner in the Industrial and Life Science Design -